Increasing concentrations (0.1 to 10 μg/mL) of anti- human GRO-α monoclonal antibody had no effect on EBC neutrophil chemotactic activity of 10 exacerbated COPD patients. The gene discussed is CXCL1; the disease is chronic obstructive pulmonary disease.